I N T R O D U C T I O N
The extracellular signaling molecule ATP exerts its canonical actions via purinergic P2 receptors, comprising the ATP-gated nonselective channels P2X1-7, and G protein-coupled P2Y receptors P2Y 1 -P2Y 13 (Jarvis and Khakh, 2009; Coddou et al., 2011; von Kügelgen and Harden, 2011) . Within the P2X subfamily, P2X7 displays the lowest affinity for ATP and a marked allosteric inhibition by extracellular divalent cations (DICs; Yan et al., 2011) . Upon repetitive or prolonged stimulation, P2X7 shows a run-up of current responses, and it allows a penetration of large cations, such as NMDG + or YoPro-1, a process that has been associated with membrane blebbing and, eventually, apoptosis induction (reviewed in Coddou et al. [2011] ). P2X7 is mainly expressed on immune cells, where it fuels inflammation by triggering interleukin-1β release. It is also expressed on a variety of cancer cells, where it has been suggested to either promote or suppress tumor progression .
During the characterization of allosteric P2X7 inhibitors, we realized that some modulators completely abrogated ATP-induced increases in [Ca 2+ ] i but only partially suppressed ATP-induced ionic currents under conditions that are typically applied in electrophysiological experiments with P2X7. To resolve this overt discrepancy, we tested the possibility that ATP had unexpectedly gated an additional, non-P2X7-associated background conductance. We found strong evidence for an as yet unrecognized activation of nonselective cation channels by ATP, closely resembling TRPM7 (melastatin-related transient receptor potential channel 7). This was unrelated to P2 receptor activation but most likely brought about by the release of these channels from a block by extracellular DICs, which are efficiently complexed by ATP when added at low millimolar concentrations that are typically required for P2X7 activation. As expected, the ubiquitously expressed TRPM7 (Fleig and Chubanov, 2014) was also present in the investigated tumor cell lines HEK293 and rat C6 glioma. The described mechanism should be considered when ascribing ATP-evoked cell responses to P2X7. TRPM7-like currents should also be taken into account when assessing the properties of P2X7 modulators especially under conditions of low extracellular cation concentrations. Future work will have to clarify whether high Within the ion channel-coupled purine receptor (P2X) family, P2X7 has gained particular interest because of its role in immune responses and in the growth control of several malignancies. Typical hallmarks of P2X7 are nonselective and noninactivating cation currents that are elicited by high concentrations (0.1-10 mM) of extracellular ATP. Here, we observe spurious ATP-induced currents in HEK293 cells that neither express P2X7 nor display ATP-induced Ca 2+ influx or Yo-Pro-1 uptake. Although the biophysical properties of these ionic currents resemble those of P2X7 in terms of their reversal potential close to 0 mV, nonrectifying current-voltage relationship, current run-up during repeated ATP application, and augmentation in bath solutions containing low divalent cation (DIC) concentrations, they are poorly inhibited by established P2X7 antagonists. Because high ATP concentrations reduce the availability of DICs, these findings prompted us to ask whether other channel entities may become activated by our experimental regimen. Indeed, a bath solution with no added DICs yields similar currents and also a rapidly inactivating Na + -selective conductance. We provide evidence that TRPM7 and ASIC1a (acid-sensing ion channel type Ia)-like channels account for these noninactivating and phasic current components, respectively. Furthermore, we find ATP-induced currents in rat C6 glioma cells, which lack functional P2X receptors but express TRPM7. Thus, the observation of an atypical P2X7-like conductance may be caused by the activation of TRPM7 by ATP, which scavenges free DICs and thereby releases TRPM7 from permeation block. Because TRPM7 has a critical role in controlling the intracellular Mg 2+ homeostasis and regulating tumor growth, these data imply that the proposed role of P2X7 in C6 glioma cell proliferation deserves reevaluation.
TRPM7 is a molecular substrate of ATP-evoked P2X7-like currents in tumor cells 
M AT E R I A L S A N D M E T H O D S

Materials and compounds
The P2X7 antagonists A-438079, A-839977, and AZ-10606120 were from Tocris Bioscience. Unless otherwise stated, all other chemicals were from Sigma-Aldrich. Stock solutions of drugs were prepared in standard or low-DIC bath solutions (ATP disodium salt, TNP-ATP [2′,3′-O-(2,4,6-trinitrophenyl) adenosine 5′-triphosphate] sodium salt), distilled water (BBG [Coomassie brilliant blue G-250], suramin), or DMSO (A-438079, A-839977, AZ-10606120, amiloride, NS-8593). Aliquots of stock solutions were stored at −20°C, and freshly diluted at the day of the experiment. The DMSO concentration in bath solutions never exceeded 0.1%, a concentration that had no effects on ATP-induced currents, Ca 2+ entry signals, and Yo-Pro-1 uptake responses in HEK hP2X7 cells. ATP stock solutions were routinely readjusted to pH 7.3 with NaOH.
Cell culture
Parental and stably transfected HEK293 cells, expressing the human P2X7 (HEK hP2X7 ), were cultured at 37°C and 5% CO 2 in Dulbecco's modified Eagle medium (DMEM; c.c.pro), containing 4.5 mM d-glucose, 10% FCS (Biochrom), 2 mM l-glutamine (PAA), and 0.05 mg/ml geneticin (Invitrogen). HEK293 cells (#CRL-1573; ATCC) were used in passages 8-26 after purchase; stable transfection was performed on cells in passage 11. Rat C6 glioma cells were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ; lot #3) and cultured for up to 20 passages in DMEM with 4.5 mM d-glucose, 10% FCS, L-glutamine, and sodium bicarbonate (DMEM; Sigma-Aldrich).
Intracellular [Ca
2+
] analysis [Ca 2+ ] i analysis in suspensions of HEK293, HEK hP2X7 , or rat C6 glioma cells was conducted in a fluorescence imaging plate reader essentially as described previously (Nörenberg et al., 2012) with the following modifications: fluo-4/AM-loaded cells were resuspended in HEP ES-buffered saline (HBS), containing 130 mM NaCl, 6 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 5.5 mM d-glucose, and 10 mM HEP ES (pH 7.4 with NaOH). Cells were dispensed into 384-well plates and exposed to the indicated modulators for 15 min. Fluorescence intensities were monitored during application of ATP. Unless otherwise stated, the final concentration of ATP was 1 mM. Background signal-corrected fluorescence intensities were normalized to the initial intensities (F 0 ) to compensate for uneven loading and fluorescence detection sensitivity.
YO-PRO-1 uptake assay HEK cell lines and rat C6 glioma cells were grown to confluent monolayers in 25-cm 2 cell culture flasks, harvested with trypsin, and resuspended in a modified HBS buffer, containing low DIC concentrations (no MgCl 2 and 0.1 mM CaCl 2 ; low DIC). 1 µM YO-PRO-1 (Thermo Fisher Scientific) was added to the cell suspension before dispensing it into 384-well microtiter plates prefilled with ATP. Experiments were conducted in a fluorescence imaging plate reader setup (Nören-berg et al., 2012) .
Western blot analysis
To study expression levels of native TRPM7, we subjected whole-cell lysates or membrane fractions of HEK293 or rat C6 glioma cells to SDS-PAGE (7% acrylamide/bis-acrylamide), electroblotted the proteins on nitrocellulose membranes, and probed the membranes after blocking with 5% (wt/vol) nonfat dry milk and 0.1% Tween 20 in phosphate-buffered saline (PBST) with recombinant rabbit monoclonal EPR4582 antibody (1:3,000; Abcam), followed by washing in PBST and incubation with horseradish peroxidase-coupled anti-rabbit lgG (1:1,000; Cell Signaling Technology) and washed again in PBST. Blots were exposed in a luminescence imager (Peqlab/VWR). As a positive control, mouse TRPM7-encoding plasmids were transiently transfected in HEK293 cells. Membrane fractions were obtained by repeatedly aspirating cell suspensions through a 0.45-mm needle, followed by pelleting at 13,000 rpm for 20 min at 4°C.
To detect P2X7 and β-actin expression, HEK293 cells or C6 glioma cells were washed with phosphate-buffered saline (PBS) and triturated (aspiration through 0.45-mm needle) in a lysis buffer, pH 7.4, containing 8 M urea, 10 mM TRIS, and 10 mM NaH 2 PO 4 . Aliquots were separated by SDS-PAGE (12.5%) and electroblotted on nitrocellulose membranes (0.45 µm; Bio-Rad Laboratories). Blots were cut at a position corresponding to 55 kD and probed with either anti-P2X7 (1:1,000; Alomone Labs; upper part of the blot) or anti-β-actin (1:3,300; Sigma-Aldrich; lower part of the blot) at 4°C overnight. After washing with PBST, blots were incubated with horseradish peroxidase-coupled goat antirabbit IgG (1:2,000; Thermo Fisher Scientific) and washed again. Bioluminescence detection was performed using a chemiluminescence kit (ECL; Thermo Fisher Scientific) and a cooled charge-coupled device camera (QSI540; Quantum Scientific Imaging).
Electrophysiology
Whole-cell or outside-out patch-clamp recordings were performed at 20-25°C and, unless otherwise stated, at a holding potential of −60 mV using an EPC9 amplifier controlled by Pulse software (HEKA). The extracellular solution contained 147 mM NaCl, 2 mM KCl, 13 mM d-glucose, and 10 mM HEP ES (∼305 mOsm/l; pH 7.3 with NaOH), supplemented with 1 mM MgCl 2 and 2 mM CaCl 2 (standard DIC) or with only 0.1 mM CaCl 2 (low DIC). A DIC-free bath (no DIC) was produced by omitting Ca 2+ and Mg 2+ and supplementing EGTA and EDTA (1 mM each) to remove any contamination with free DICs. Other extracellular solutions with a defined free [Ca 2+ ] were prepared by adding the required amounts of Ca 2+ to the no-DIC solution as calculated with a MaxChelator software. Patch pipettes had a resistance of 2-5 MΩ, when filled with intracellular solutions. These were either identical with the no-DIC saline (outside-out patches) or contained 147 mM KCl, 10 mM HEP ES, 10 mM EGTA (∼300 mOsm/l; pH 7.3 with KOH; whole-cell configuration). In some experiments, 3 mM of MgCl 2 (MaxChelator) was added to either of the two pipette solutions. Drugs were applied to patched cells by means of a pressurized superfusion system (OCT AFL OW-II; ALA Scientific Instruments). Whole-cell currents (filtered at 1.7 kHz, sampled at 5 kHz) were measured as peak amplitudes and normalized for membrane capacitance to obtain current densities (pA/pF). Experiments during which series resistance (compensated by 60-80%) changed by >20% were discarded. Single-channel currents from outside-out patches were digitized at 20 kHz and filtered at 2 kHz. Qin, 2004) was 200 µs, thereby excluding events shorter than this duration from analysis. The SKM approach has, because of a high tolerance for noise, a low tendency for false event recognition, and its accuracy is in addition largely insensitive to the kinetic model, i.e., to the number of states and/or the initial rate constants used (Qin, 2004) . The mean intraburst closed (T C ) and open times (T O ) given were averages derived from the noise-free idealization. SKM-derived dwell times were additionally displayed as histograms of square root-transformed, log-distributed data and overlaid with theoretical distributions (probability density functions) to provide a supplementary visual check for multiple peaks (i.e., kinetic components; Sigworth and Sine, 1987;  for examples see Fig. 5 [C and D] ).
All data were expressed as mean ± SEM, obtained in n cells or experiments. Differences in means were tested for significance by the Mann-Whitney U test or by the Kruskal-Wallis one-way ANO VA on Ranks followed by a modified Student's t test (Bonferroni-Dunn) in the case of single and multiple comparisons, respectively. P-values are stated in the figures and in the text. ] o . Fig. S3 shows knockdown of TRPM7, but not P2X7, suppresses sustained no-DIC-induced current in HEK hP2X7 cells. Fig. S4 In a stably transfected, P2X7-expressing cell line (HEK hP2X7 ), whole-cell currents elicited by 1 mM ATP were largely, but not completely inhibited by a combination of a broad-spectrum P2X receptor blocker (30 µM TNP-ATP) and a P2X7-specific antagonist (0.3 µM AZ-10606120; Fig. 1 A) . When subjecting the parental HEK293 cell line, which is not expected to express P2X7, to the same protocol, 1 mM ATP also induced inward currents (Fig. 1 B) . These spurious currents were smaller in size and not sensitive to the combined application of TNP-ATP and AZ-10606120 ( Fig. 1 B) . Nonetheless, they shared some properties that are typical for a P2X7-like conductance, including a noninactivating phenotype, a current run-up during repeated pulses of ATP application (Fig. 1, C and D) , an almost linear I/V relationship with a reversal potential close to 0 mV (−3.8 ± 0.6 mV in HEKhP2X7 cells vs. −3.6 ± 0.9 mV in parental HEK293 cells; Fig. 1 , E and F), and a requirement of high ATP concentrations for current activation (Fig. 1 , G-J). With a lack of a saturating effect at ATP concentrations of 1-10 mM, the concentration dependence of ion currents in parental HEK293 cells seemed to differ from that seen in the HEK hP2X7 cell line.
Because neither Ca 2+ entry nor Yo-Pro-1 uptake were detectable in ATP (1-5 mM)-stimulated parental HEK293 cells (not depicted) and because endogenous P2Y 1 and P2Y 2 receptors in HEK293 cells are unlikely to require more than 10 µM ATP for activation, we considered that these background currents may be unrelated to P2 receptors in general. We therefore aimed at clarifying the molecular correlate of these unexpected ATP-induced background currents. Drops to low [Ca 2+ ] o evoke two types of current responses in HEK hP2X7 cells
To explore the possibility that millimolar concentrations of ATP may complex a substantial fraction of DICs in the bath solution and thereby release yet to be identified channels from a DIC block, we exposed HEK hP2X7 cells to bath solutions that contained the same calculated free Ca 2+ concentrations that would remain in low-DIC bath solutions, supplemented with 0.1-10 mM ATP (Fig. 2 A) . To this end, HEK hP2X7 cells were kept in standard DIC and then acutely exposed to test solutions with stepwise decrements of [Ca 2+ ] o to 100 µM Ca 2+ (low DIC) or 76.5, 21.3, or 2.4 µM free Ca 2+ , corresponding to the calculated concentrations upon addition of 0, 0.1, 1, and 10 mM ATP to low-DIC bath solutions. In addition, a Ca 2+ -free solution (no DIC) was applied. Under these conditions, we observed two current components, which both displayed an inverse [Ca 2+ ] o concentration dependence. A transient inward current component was seen at [Ca 2+ ] o ≤ 76.5 µM and partially deactivated during repeated application of the Ca ] o sensitivity (Fig. 2 I) , indicating that they are conducted by distinct channel entities. The transient inward currents were sensitive to 10 µM amiloride (Fig. S1 ) and are presumably carried by ASIC1a channels known to be expressed in HEK293 cells (Gunthorpe et al., 2001 ) and to shift their pH dependence to more neutral values in a [Ca 2+ ] o -dependent manner (Babini et al., 2002; Sherwood et al., 2012) . A more detailed description is provided in the Supplemental text. Notably, the amplitudes of the noninactivating currents evoked by acutely lowering [Ca 2+ ] o in HEK hP2X7 cells matched fairly well those of the ATP-induced currents in parental HEK293 cells (Fig. 2 I) or of TNP-ATP-and AZ-10606120-resistant residual currents that remained in ATP-stimulated HEK hP2X7 cells (Fig. 1 A) , suggesting that the ATP-induced background current may be present in both cell lines and is only indirectly triggered by chelation of extracellular DICs.
Noninactivating whole-cell currents induced by ATP or by low [Ca 2+ ] o share regulatory properties with TRPM7
We first wanted to know which channel may mediate currents that were triggered by lowering [Ca 2+ ] o . During application of slow voltage ramps, outwardly rectifying currents were evident in HEK293 cells (not depicted) or in HEK hP2X7 cells patched with a Mg 2+ -free pipette solution in the presence of extracellular DICs (Fig. 3, A and B). After changing to no-DIC solution, inward and outward currents strongly increased, associated with a linearization of the I/V relationship, which reversed at −6.0 ± 1.6 mV (n = 10; Fig. 3, A and B) . These features are most likely caused by the same channel, which is released from a voltage-dependent inhibition by extracellular DICs and closely resemble the properties of the poorly selective and Mg 2+ -inhibited cation channel TRPM7 (Nadler et al., 2001) , which is widely expressed in untransformed or in tumor cells, including HEK293 (Chubanov et al., 2004) . Western blot analysis confirmed the TRPM7 expression in parental HEK293 and in HEK hP2X7 cell lines (Fig. 3 C) . If TRPM7 was the activated channel, we would expect a strong suppression by intracellular Mg 2+ . Indeed, including 3 mM MgCl 2 in the pipette solution abrogated the sustained current component that was induced by a Ca 2+ -free bath solution (Fig. 3, D and F) . Instead, the transient inward currents that were still inducible by removing [Ca 2+ ] o now became unmasked and isolated (Fig. 3 , E and G). Of note, the transient current component was inwardly rectifying and reversed at >40 mV, strongly indicating a Na + -selective conductance. Because the ATP-induced background current, which remained in the presence of TNP-ATP and AZ-10606120, was also abolished by including 3 mM MgCl 2 in the pipette solution (Fig. 4 , A-C), it appeared likely that this background current is caused by an activation of TRPM7. Consistently, 30 µM NS-8593, a compound that has previously been shown to inhibit TRPM7 (Chubanov et al., 2012) , caused a reduction of current densities (Fig. 4, D and E) . We conclude that TRPM7 may mediate ATP-induced background currents that appear under conditions that are frequently applied to analyze P2X7. To confirm that TRPM7 is the molecular correlate, the biophysical fingerprint of TRPM7, favorably by single channel analysis, would have to be assessed.
ATP-and low [Ca
2+
] o -activated single channel currents are virtually undistinguishable and resemble TRPM7
If TRPM7 was the channel that is activated by chelation or removal of extracellular DIC, we would expect to observe a single channel conductance of ∼40 pS (Li et al., 2006) . Because the unitary conductance of P2X7 is 9-10 pS (Riedel et al., 2007) , single channel analysis should yield a distinction between these channel entities. Outside-out patches were obtained from nontransfected HEK293 cells and voltage clamped to −60 mV in a bath solution containing standard DIC. After reaching stable seals (2-10 min), patches were exposed to no-DIC bath solution, which gave rise to bursts of channel activity in 14 out of 18 patches. In 8 out of 14 channel-containing patches, a single open level was seen (Fig. 5 A) . Amplitude histograms revealed a unitary conductance of 41.2 ± 1.5 pS, indicating TRPM7 activity. When challenged with 10 mM ATP in low-DIC solution (inducing a calculated [Ca 2+ ] o of 2.4 µM), again single channel activity appeared in 8 out of 14 patches, but with markedly shorter opening events and an apparent unitary conductance of 25.8 ± 0.7 pS (Fig. 5 B) . If 3 mM MgCl 2 was included in the pipette solution, neither removal of extracellular DIC nor exposure to ATP induced a single channel activity (n = 7 for each setting; not depicted), arguing for the [Mg 2+ ] i -inhibited TRPM7 channel as the common molecular correlate. The overt dissimilarities between single channel properties elicited by no-DIC solution or by 10 mM ATP in low DIC, however, prevent the unequivocal assignment of TRPM7 being the channel, which is indirectly activated by ATP.
The calculated mean open times during activity bursts were 49.4 ± 5.8 ms and 2.7 ± 0.8 ms for single channel openings induced by no DIC and ATP, respectively (P < 0.001, n = 8; Fig. 5 , C-E). Other significant differences were the lower apparent intraburst open probability, smaller unitary current amplitudes, and notably, an ∼1.5-fold higher excess open channel noise (σ ex /i) upon ATP-induced compared with low-DIC-mediated currents (Fig. 5 E) . The increased excess channel noise indicates a possible underestimation of the single channel conductance, caused by a fast block of the channel in the ATP-activated mode, which cannot be resolved within the methodological restrictions imposed by the If distinct kinetic properties can be adopted by the same channel, we would expect that, in an excised patch with a single level of channel openings, acute switching from one to the other activation mode should demonstrate that these features reflect interconvertible states of a single channel. In outside-out patches exposed to 10 mM ATP in low DIC, the aforementioned flicker channel activity was observed and, upon switching to no DIC, successively converted into the more stabilized openings (Fig. 6 A) . Switching back to ATP in low DIC immediately reestablished the channel flickering. During this procedure, the apparent single channel conductance also converted from ∼25 pS to 40 pS and back to 25 pS. Because similar reversible conversion of single channel properties was achieved with ATP included in the no-DIC solution (Fig. 6, B and D (Fig. 6, C and D) . As a second line of evidence, we could demonstrate that the ATP- induced channel activity shares the voltage dependence of Ca 2+ to preferentially block the TRPM7-like conductance in excised patches at negative potentials. At positive potentials, both the fast block (reflected by the apparently reduced single channel conductance) and the slower, flickering block (reflected by shortening of mean open times) were overcome (Fig.  S2 ), indicating that [Ca 2+ ] o impedes TRPM7 activity by binding within the electrical field of the membrane. Because [Ca 2+ ] o clamped to 2.4 µM mimicked the effect of extracellular ATP in low-DIC solutions, our conclusion is that partial activation of TRPM7 by releasing it from a Ca 2+ -dependent block is the most likely molecular candidate to mediate sustained nonselective cation currents under conditions that are frequently applied to measure P2X7 channels. Finally, to confirm that dis-inhibition by low [Ca 2+ ] o of TRPM7-like single channel activity is responsible for global currents seen in the whole-cell mode upon lowering [Ca 2+ ] o , we performed siRNA-mediated knockdown of TRPM7 expression, which resulted in a significant inhibition of no-DIC-induced whole-cell currents in HEK hP2X7 cells compared with untransfected or control siRNA-or P2X7 siRNA-transfected cells (Fig. S3 ).
Strategies to avoid TRPM7-like channel coactivation while assaying P2X7
The strong enhancement of P2X7 currents in low-DIC solutions prompts researchers to use such conditions during electrophysiological recordings of P2X7 receptor activation. If more physiological DIC concentrations are contained in the bath solution, TRPM7 coactivation is disfavored. Nonetheless, it should be noted that ATP concentrations ≥1 mM evoke TRPM7-like currents also in a standard DIC bath (Fig. S4 ). Although these currents are much smaller compared with those in no-DIC solutions, P2X7 currents would also become tinier, and the concentration-response curve for ATP is shifted to higher ATP concentrations, thereby increasing DICchelating capacity. Therefore, our data imply that alternative strategies should be used to prevent a coactivation of the ubiquitously expressed TRPM7. Because the pharmacological inhibitor waixenicin (Zierler et al., 2011) is not readily available, the inclusion of 1-5-mM concentrations of Mg 2+ in the pipette solution is expected to reliably suppress TRPM7. In HEK hP2X7 cells that were intracellularly perfused with Mg 2+ , current densities were ∼30% smaller than in cells that were recorded with a Mg 2+ -free intracellular solution (Fig. 7 A) . When recorded with a Mg 2+ -free pipette solution, addition of established competitive or noncompetitive P2X7 receptor antagonists AZ-10606120 (0.3 µM), A-438079 (10 µM), and A-839977 (1 µM) to the bath solution only partially suppressed 1 mM ATP-induced currents with a remaining current of ∼20-25% (Fig. 7, B and  D) . In contrast, ATP-induced inward currents were abolished when HEK hP2X7 cells were intracellularly perfused with 3 mM Mg 2+ and then stimulated with 1 mM ATP (Fig. 7, C and D) . Thus, contaminating TRPM7-like currents may cause an underestimation of antagonist efficacy. Although the apparent antagonist-resistant fraction already amounted 20-25% in the strongly P2X7-expressing stable cell line, it can be substantially larger in cells that natively express low physiological levels of P2X7, such as macrophages or astrocytes (Nörenberg et al., 2012) . A possible drawback of the intracellular availability of Mg 2+ is that numerous signaling cascades, including ATP-induced P2Y receptor activation and downstream signaling via Mg 2+ -GTP-dependent heterotrimeric G proteins may cause regulation of various other ion channel families that may overlap with the observed P2X7 currents.
ATP activates TRPM7-like currents but not P2X7 currents in rat C6 glioma cells
We finally asked whether dis-inhibition of TRPM7 by millimolar ATP concentrations might have contributed to the assumption of functional expression of P2X7 in cells that endogenously express substantial amounts of TRPM7. We selected rat C6 glioma cells as an example for which P2X7 expression has been reported (Wei et al., 2008; Ryu et al., 2011) . Like in parental HEK293 cells, addition of concentrations of ATP (1.25 or 5 mM) that reliably activate P2X7 failed to induce a P2X7-typical, long-lasting increase in [Ca 2+ ] i in C6 glioma cells (Fig. 8, A and B) . Of note, a lower signal peak was consistently observed in HEK hP2X7 cells stimulated with 5 mM ATP compared with 1.25 mM ATP (Fig. 8 B) . Be- ] o (dark gray bars). *, P < 0.001, significantly different from the channel activity evoked by no DIC; ns, not statistically significant; n = 7-9 each. Single channel parameters were derived from a 1.75-s recording period before bath exchange (ATP in low DIC, 2.4 µM [Ca 2+ ] o ) or from the last 2.5 s in no DIC and ATP in no DIC, respectively, and included 65-983 dwells. In electrophysiological figures, dotted lines indicate the zero current level.
cause a bell-shaped concentration response curve is not reported for P2X7 currents, this effect is most likely caused by a lower availability of free extracellular Ca 2+ in the presence of excess amounts of ATP. An ATP-induced transient increase in [Ca 2+ ] i was seen in the glioma cells (Fig. 8 A) but not significantly affected by the P2X7-selective antagonist AZ10606120 (100 nM). Similarly, Yo-Pro-1 uptake was not detectable in ATP-stimulated C6 glioma cells but clearly present in HEK hP2X7 cells (Fig. 8 C) . Western blot analysis confirmed the presence of TRPM7 in C6 glioma cells (Fig. 3 C) , whereas no P2X7 expression was detected despite species cross-reactivity of the antibody (Fig. 8 D) .
Whole-cell currents that were detected with a Mg 2+ -free pipette solution in C6 glioma cells challenged with 10 mM ATP in a low-DIC solution showed a noninactivating inward current (at −60 mV) and an amplitude run-up during repeated stimulation (Fig. 9, A and C) . As judged from their reversal potential (−2.8 ± 3.4 mV; n = 7), these currents were conducted by nonselective cation channels. In contrast to P2X7 currents, the responses were not significantly inhibited by a combined addition of 30 µM TNP-ATP and 0.3 µM AZ-10606120 (Fig. 9, D and E) but abolished upon inclusion of 3 mM MgCl 2 in the pipette solution (Fig. 9, B and C) . The finding of similar [Mg 2+ ] i -inhibitable currents being evoked by superfusing C6 cells with no-DIC solution (Fig. 9, F-H) corroborates the notion that dis-inhibition of a nonselective cation channel from a DIC-dependent block rather than ATP binding to a channel target has mimicked the responses.
To ascertain that TRPM7 is the channel carrying the nonselective cation currents, we conducted a ramp protocol to activate TRPM7 in the same fashion as done in HEK hP2X7 cells (Fig. 3 A) . The outwardly rectifying currents converted to almost linear I/V relationship upon removal of extracellular DIC (Fig. 10, A and B) , indicating functional expression of TRPM7. As expected, the no-DIC-evoked inward currents in C6 glioma cells were strongly inhibited by 30 µM NS-8593 but not by the P2X7-specific inhibitors AZ-10606120, A-438079, or A-839977 (Fig. 10, C , D, and G), which were applied at concentrations that are effective on P2X7 (Fig. 7 D) .
Previously, beneficial effects of systemically administered BBG were observed in an experimental therapy model based on orthotopically implanted C6 glioblastoma and were attributed to a modulation of P2X7 (Ryu et al., 2011) . In the light of our findings, we tested the impact of BBG on TRPM7-like currents in C6 glioma cells. Indeed, when applied at increas- ] i ; n = 9-11 each). ATP-induced peak currents in the presence of 0.3 µM AZ-10606120, 10 µM A-438079, or 1 µM A-839977 were normalized to the respective pre-application peak currents (I 1 ). Significant differences to the DMSO controls (*, P < 0.001) and significant differences to the respective drug effects obtained with 0 mM [Mg 2+ ] i (**, P < 0.001) are depicted. Recordings were performed in low-DIC bath after current run-up in response to repetitive stimulation with 1 mM ATP was completed (not depicted). In electrophysiological figures, dotted lines indicate the zero current level. Error bars indicate SEM.
ing concentrations, BBG exerted a complex interference with the TRPM7-like conductance. Although 100 nM BBG potentiated the no-DIC-induced inward currents, 1-10 µM BBG caused an ∼50% inhibition of the TRPM7-like conductance (Fig. 10 , E-G), indicating a possible involvement of TRPM7 in the previously observed effects.
D I S C U S S I O N
The main finding of the present study was that extracellular ATP concentrations that are commonly applied to stimulate P2X7 receptors can evoke cellular responses, which are not mediated by a purinergic receptor. This noncanonical effect comprises the induction of a nonselective cation conductance, presumably by dis-inhibition of the ubiquitously expressed TRPM7 channel. The membrane currents had some properties that are commonly regarded as typical for P2X7, including the requirement of millimolar ATP concentrations for activation, inhibition by ambient DICs, a nonselective cation conductance with an almost linear I/V relationship at membrane potentials between −100 and 40 mV, and a gradual run-up of responses upon recurrent stimulation. Hence, some precautions should be taken to avoid misclassification of ATP responses by means of electrophysiological techniques. The analysis of additional features is suggested to distinguish the noncanonical ATP-induced TRPM7-like currents from those conducted by P2X7. These include the application of highly potent and selective P2X7 antagonists and the inhibition of TRPM7 by intracellular Mg 2+ . Fluorometric [Ca 2+ ] i or Yo-Pro-1 uptake assay should be less prone to misjudgments because TRPM7 has been shown to possess only a limited Ca 2+ permeability (Monteilh-Zoller et al., 2003) and has no discernable permeability for the organic cation Yo-Pro-1.
Receptor-independent, pleiotropic mode of action of extracellular ATP
In both cell models applied in this study, our data suggest a receptor-independent action of ATP. HEK293 cells have been shown to express at least P2X4 and P2X5 (Worthington et al., 1999) , from which hP2X5 turned out to constitute a nonfunctional deletion mutant (Duckwitz et al., 2006) , whereas rat C6 glioma cells may be endowed with P2X7 (Wei et al., 2008) . All known functional P2X receptor subtypes are, however, suscep- tible to the inhibitory effects of either TNP-ATP or AZ-10606120 (Jarvis and Khakh, 2009; Coddou et al., 2011) . Because the noncanonical currents evoked by ATP in both tumor cell lines were not affected by a mixture of these antagonists, they were decisively not conducted by P2X receptor channels. This view is strongly supported by the failure to perceive ATP-induced changes in [Ca 2+ ] i or in Yo-Pro-1 uptake and by single channel properties that are incompatible with those of P2X7.
The P2X4 protein described in HEK293 cells (Worthington et al., 1999) was thus apparently not assembled into functional channel complexes or, if they were so, not targeted to the cell membrane. Accordingly, P2X4 is known to be largely compartmentalized within cytoplasmic structures such as vesicles, vacuoles, lamellar bodies, and lysosomes (Xu et al., 2014) . With respect to the proposed presence of P2X7 in rat glioma (Wei et al., 2008) , we could, however, not detect the respective protein. The rat C6 cells of this previous study were used after unusually high cell passage numbers (39-59 times; Wei et al., 2008) , during which they may have gained astrocyte-like properties (Mangoura et al., 1989), and rat cultured astrocytes were in fact endowed with functional P2X7 receptors (Nörenberg et al., 2010) .
Previous studies have described functional P2Y subtypes in HEK293 (Schachter et al., 1997) and rat C6 glioma cells (Sabała et al., 2001; Van Kolen and Slegers, 2004) . However, metabotropic receptors were definitely not implicated in the activation of the atypical ATP responses. The latter could not only be elicited in the absence of intracellular Mg 2+ , i.e., when an indispensable prerequisite for GDP/GTP exchange and therefore for G protein-dependent signaling was lacking (Birnbaumer, 2007) , but were in fact abolished by its substitution. Also, ATP effects on endogenous P2Y 1 and P2Y 2 receptors expressed in HEK293 cells require markedly lower agonist concentrations (Schachter et al., 1997) than the development of nonselective cation currents seen in this study.
Mechanism of the noncanonical ATP effect
The P2 receptor-independent biological effect of ATP was closely mimicked by further reducing the extracellular Ca 2+ concentration, suggesting that the Ca 2+ -and Mg 2+ -buffering capability of ATP was causing dis-inhibition of a DIC-inhibited channel. Accordingly, we found that acute lowering of [Ca 2+ ] o was sufficient to trigger membrane current responses. Depending on the cell type, two different types of conductivity were found. TRPM7-like whole-cell currents at −60 mV, recorded after preconditioning (not depicted), were elicited by repetitive exposure (6 s at 30-s intervals) to no DIC before (left; I 1 ) and 6 min after exposure to the indicated TRPM7 and P2X modulators (middle; I 2 ). (right) Currents 6 min after wash-out of the test compounds. (G) Statistical analysis of experiments as in A-E (n = 7-9 each). TRPM7-like peak currents in the presence of the test compounds (I 2 ) are normalized to the respective pre-application peak currents (I 1 ). *, P < 0.001, significantly different from the control condition (DMSO). In electrophysiological figures, dotted lines indicate the zero current level. Error bars indicate SEM.
One type, a nondesensitizing current, closely mimicked the noncanonical ATP currents in HEK293 and in rat C6 glioma cells. The other response type was only seen in HEK293 cells. It comprised a rapidly desensitizing Na + current with inwardly rectifying I/V relationship and was pharmacologically addressable with amiloride, suggesting that ASIC1a is the underlying molecular entity (Gunthorpe et al., 2001 ). However, ASIC1a was not activating during application of ATP because it was actually inhibited by ATP (see Fig. S1 ).
The cation conduit for the noncanonical ATP effect was found to be the constitutively active, but Mg 2+ -and Ca 2+ -inhibited TRPM7 channel, whose expression has already been described in HEK293 cells (Nadler et al., 2001; Chubanov et al., 2012) . Extracellular Ca 2+ or other DICs are permeant to some degree, but they strongly bind to the selectivity filter and thereby limit inward currents through the obstructed pore. Removal of extracellular DIC releases this permeation block, thereby changing the outwardly rectifying behavior of partially blocked TRPM7 to a linear current-voltage response (Nadler et al., 2001; Runnels et al., 2001; Kerschbaum et al., 2003; Monteilh-Zoller et al., 2003) .
TRPM7 is tightly regulated by the intracellular concentration of Mg 2+ , an effect that involves two separate binding sites, one for Mg-ATP within the inherent cytoplasmic kinase domain of the protein and another for free Mg 2+ located within the channel moiety (Schmitz et al., 2003; Demeuse et al., 2006) . There are several lines of evidence that the Mg 2+ -inhibited TRPM7 is carrying the noncanonical ATP-induced currents, including the sensitivity to NS-8593, a published TRPM7-inhibiting compound (Chubanov et al., 2012) , the absence of responses in recordings using Mg 2+ -containing pipette solutions, and most strikingly, the single channel data, showing typical 40 pS channels (Li et al., 2006) under complete Ca 2+ removal, which are converted to a somewhat smaller and flickering conductance in the presence of 2.4 µM Ca 2+ irrespective of the presence or absence of ATP (Fig. 6) . Finally, transfection of a TRPM7-targeting siRNA strongly attenuated the responses to no-DIC solutions. The impact of either extracellular ATP or direct lowering of Ca 2+ on single channel properties was strongly voltage dependent. Thus, it may be explained by fast and slower binding/dissociation to negatively charged amino acids that experience the electrical field of the cell membrane. Indeed, negatively charged amino acids that align the selectivity filter in the pore-forming region of TRPM7 have been shown to critically regulate permeation of and inhibition by DICs (Mederos y Schnitzler et al., 2008; Numata and Okada, 2008) . It should be noted that we found TRPM7 to be expressed in rat C6 glioma cells, making it likely that ATPinduced currents are indeed mediated by TRPM7 and not via P2X7. TRPM6, the closest phylogenetic relative of TRPM7, is mainly expressed in the kidney, the intestine, and the testis and shares important regulatory properties with TRPM7. These include the chanzyme structure, as well as the regulation by intracellular Mg 2+ and extracellular DICs (Chubanov and Gudermann, 2014) . There is ongoing debate as to whether TRPM6 can form functional channels on its own (Chubanov and Gudermann, 2014) . If coexpressed with TRPM7, TRPM6 can form functional heteromeric channel complexes (Chubanov et al., 2004; Li et al., 2006) . Hence, TRPM6 or TRPM6-bearing heteromeric complexes may share the same indirect ATP-dependent mode of disinhibition from an extracellular block, thereby contributing to noncanonical ATP-induced currents in specific tissues.
Possible biological implications
We do not assume that the newly described pleiotropic mechanism is involved in the gross physiological regulation of TRPM7 (or TRPM6) channel activity, even though respective current responses could be evoked in the presence of standard levels of extracellular DICs. It may play a role, however, in injured tissues, where massive amounts of ATP can leak out from damaged cells into a restricted extracellular space. Accordingly, there is evidence showing that TRPM7 can promote the death of cortical and hippocampal neurons under conditions of glucose/oxygen deprivation or cerebral ischemia (e.g., Aarts et al., 2003; Wei et al., 2007) . Interestingly, it has been proposed that TRPM7 may be activated by a decrease in extracellular DICs, possibly via GluN (NMDA) receptor hyperactivity (Wei et al., 2007) . Our data suggest that extracellular ATP may contribute to TRPM7 disinhibition as well.
In contrast, malignant tumors are known to frequently develop diffuse necrotic foci upon vascular insults, which then may cause leakage of ATP (Di Virgilio, 2012) but also compromise TRPM7 gating control in tumor cells around the hypoxic area because the intracellular regulatory sites for Mg-ATP and Mg 2+ synergistically impede channel activity (Demeuse et al., 2006) . Paracrine effects of ATP on cancer growth may thus be mediated in principle by TRPM7 (Fleig and Chubanov, 2014) and P2X7 (Di Virgilio, 2012), which both have been shown to potentially promote tumor cell proliferation (Tani et al., 2007; Adinolfi et al., 2012) and invasiveness (Clark et al., 2006; Jelassi et al., 2011) . With respect to gliomas, the P2X7 antagonist BBG has been shown to suppress tumor growth after the injection of rat C6 cells into the brain (Ryu et al., 2011) . However, we and others (Supłat-Wypych et al., 2010) were unable to find any evidence for functional P2X7 (or other P2X) receptors in this tumor cell line. Because our data demonstrate that BBG also modulates TRPM7, one should consider that this and presumably more molecular targets may account for the observed antitumor properties of BBG.
